Evaluation of the safety and feasibility of foam injection combined with laser treatment for varicose veins

Not Applicable

Completed

• Conditions: Varicose veins; Circulatory System

• Registration Number: ISRCTN17095383
• Lead Sponsor: Sakurabashi Watanabe Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2021-09-02
• Study Start: 2022-03-09
• Last Update Posted: 7 August 2023

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 134

Inclusion Criteria

Patients with unilateral or bilateral varicose veins of the SSV with clinical class C2 to C6 disease using the clinical, etiologic, anatomic, and pathophysiologic (CEAP) classification

Exclusion Criteria

1. Recurrent varicose veins after previous surgery, EVLA, or foam sclerotherapy
2. A hypersensitivity reaction to sclerotherapy
3. Acute deep vein thrombosis (DVT) or a history of DVT
4. Severe lower limb ischaemic disease (lower extremity arteriosclerosis obliterans, thromboangiitis obliterans, acute arterial embolism, or Raynaud syndrome)
5. Coagulation disorder
6. Indications for simultaneous EVLA in both the GSV and SSV

Study & Design

• Study Type: Interventional
• Study Design: Not specified